{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:23:36Z","timestamp":1790166216108,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.047","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T09:17:44Z","timestamp":1526375864000},"page":"181-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21"],"prefix":"10.1016","volume":"104","author":[{"given":"Ziye","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.05.047_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2000.02137.x","article-title":"The story of chronic myeloid leukaemia","volume":"110","author":"Geary","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2018.05.047_bib0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-005-1039-z","article-title":"Chronic myeloid leukemia: a model for oncology","volume":"84","author":"Hehlmann","year":"2005","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.biopha.2018.05.047_bib0015","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2010.143","article-title":"Critical molecular pathways in cancer stem cells of chronic myeloid leukemia","volume":"24","author":"Chen","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2018.05.047_bib0020","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.05.047_bib0025","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.05.047_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fgene.2012.00219","article-title":"Long non-coding RNAs in cancer progression","volume":"3","author":"Tano","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.biopha.2018.05.047_bib0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.05.047_bib0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2013.01.003","article-title":"Braveheart, a long noncoding RNA required for cardiovascular lineage commitment","volume":"152","author":"Klattenhoff","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.05.047_bib0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12185-014-1552-8","article-title":"Long noncoding RNAs during normal and malignant hematopoiesis","volume":"99","author":"Alvarez-Dominguez","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.biopha.2018.05.047_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-10-2483","article-title":"Long intergenic noncoding RNAs: new links in cancer progression","volume":"71","author":"Tsai","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.05.047_bib0055","doi-asserted-by":"crossref","first-page":"19054","DOI":"10.18632\/oncotarget.7764","article-title":"Associations between polymorphisms of long non-coding RNA MEG3 and risk of colorectal cancer in Chinese","volume":"7","author":"Cao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.05.047_bib0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-017-3238-4","article-title":"Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2018.05.047_bib0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.28882","article-title":"Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay","volume":"65","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.05.047_bib0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4062\/biomolther.2016.162","article-title":"LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing MicroRNA-21","volume":"25","author":"Zhou","year":"2017","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.biopha.2018.05.047_bib0075","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.05.047_bib0080","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","article-title":"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression","volume":"70","author":"Zhang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.05.047_bib0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13046-016-0472-2","article-title":"Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.05.047_bib0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1074\/jbc.M116.750950","article-title":"MEG3 Long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines","volume":"292","author":"Terashima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.047_bib0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","article-title":"microRNAs: tiny regulators with great potential","volume":"107","author":"Ambros","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2018.05.047_bib0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1535-7163.MCT-17-0925","article-title":"MicroRNA-203 inhibits long noncoding RNA HOTAIR and regulates tumorigenesis through epithelial-to-mesenchymal transition pathway in renal cell carcinoma","volume":"17","author":"Dasgupta","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2018.05.047_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-017-0218-x","article-title":"MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2018.05.047_bib0110","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.3892\/mmr.2017.7440","article-title":"MicroRNA21 increases cell viability and suppresses cellular apoptosis in nonsmall cell lung cancer by regulating the PI3K\/Akt signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2018.05.047_bib0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.21328","article-title":"Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas","volume":"44","author":"Luo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2018.05.047_bib0120","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.05.047_bib0125","first-page":"1115","article-title":"Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes","volume":"5","author":"Ries","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2018.05.047_bib0130","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","article-title":"Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in matrigel implants","volume":"16","author":"Janowska-Wieczorek","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2018.05.047_bib0135","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","article-title":"microRNAs: tiny regulators with great potential","volume":"107","author":"Ambros","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.05.047_bib0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41419-017-0218-x","article-title":"MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218317852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218317852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:27:39Z","timestamp":1760095659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218317852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S0753332218317852"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.047","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}